
world
Immunotherapy bowel cancer drug works for 100% of patients – researchers
Jemperli (also called dostarlimab) from GSK showed “unprecedented results”, the firm said, with no evidence of disease in all patients treated
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC